While developing an athlete marketing platform at LA28, Zayleen Jemuhamed faced significant internal resistance. To overcome the stalemate, she pushed the organization to launch despite lacking consensus, arguing "Let's just go. Even if we test and change." This shows that forcing action is critical to bypass institutional naysayers.

When facing severe financial pressure and a low stock price, a CEO's instinct to protect their team can be the right long-term move. Paul Friedman of Incyte resisted board demands for downsizing, arguing the financial impact would be minimal while the cultural damage would be irreversible, and successfully found alternative funding instead.

To successfully acquire a shelved asset from a large pharma company, you must find a high-level internal advocate—what Annette Bakker calls a "Frida." This person must believe in the project and possess the influence to navigate internal bureaucracy and champion the out-licensing effort, which is often complex and not a corporate priority.

After 15 years of struggle with no clear path forward, Paul Rosolie privately decided to give up on his dream. Just one week later, he received the call from a billionaire funder that greenlit his entire conservation project. This suggests that the moment of surrender can often precede a major breakthrough.

After being rejected three times, Home Depot's banker Rip Fleming threatened to resign, telling his CEO he'd rather lose his job than fail to back good people like Marcus and Blank. This act of extreme partnership, unknown to the founders for years, saved the company.

Paul Friedman's drug SUSTIVA was nearly canceled by Merck after severe toxicity in animal trials. By trusting a small group of pharmacokineticists who hypothesized a "rodent-specific phenomenon," Friedman approved further experiments. This decision, against initial leadership consensus, revived the program and led to a foundational HIV drug.

When leadership rejects a high-conviction idea, find unconventional ways to fund and build a proof of concept internally. The success of this 'bootstrapped' project can force leadership to recognize its value, turning a 'no' into a corporate achievement award.

Middle managers often feel threatened by new ideas from their teams and become innovation blockers. A pragmatic solution shared by one executive is for frontline employees to bypass this layer and seek approval for experiments directly from senior leadership, who are often more receptive.

While most of the company was demoralized and quitting, the intense, optimistic energy of a small, isolated team working on the breakthrough product provided the founder with the psychological fuel to persevere through the company's darkest period.